FoxO1, a member of the forkhead rabdomyosarcoma (FoxO) subfamily of transcription factors, binds DNA via a highly conserved winged-helix "forkhead box" motif used by other regulatory proteins to mediate their effects through chromatin binding and remodeling. To examine how FoxO1 regulates target genes in chromatin, we studied the binding of purified recombinant FoxO1 protein to nucleosome particles and chromatin arrays containing the insulin-like growth factor-binding protein 1 promoter. We found that FoxO1 is able to bind to its cognate sites within the insulin-like growth factor-binding protein 1 promoter on a nucleosome. This binding stably perturbs core histone:DNA contacts extending up-and downstream from sites of FoxO1 binding without disrupting the underlying core particle. FoxO1 is able to harness these capabilities to bind to and de-condense linker histone-compacted chromatin arrays. Chromatin opening by FoxO1 requires both the N and C termini of the protein, which are also required for high affinity core histone binding and, in the case of the N terminus, nucleosome perturbation. We suggest that the chromatin binding and remodeling functions revealed here for FoxO1 endow all FoxO factors with the ability to initiate and dynamically modulate active chromatin states, enabling their diverse roles as gene regulatory factors in metabolism, cell survival, apoptosis, cell cycle progression, DNA repair, and protection against oxidative stress.
Transcriptional regulation of eukaryotic genes occurs through the coordinated binding and interaction of multiple regulatory factors at promoters and enhancers. Because the eukaryotic genome is assembled into chromatin, it follows that transcriptional activation in eukaryotes occurs in the context of DNA organized into higher order chromatin structure. Chromatin is organized into repeating units of nucleosome core particles made up of nearly two turns of DNA wrapped around an octamer of the four core histone proteins, H2A, H2B, H3, and H4, and further condensed by binding of the linker histone H1. Higher order folding and oligomerization of H1-compacted chromatin, together with core histone:DNA contacts within individual nucleosome cores, block access of transcription factors to their cognate DNA sequences. It follows that, in order for transcription activation to occur, chromatin at regulatory regions must be remodeled to allow transcription factors access to the DNA. The perturbations in chromatin structure required to poise genes for activation and modulate their expression are mediated, at least in part, by certain regulatory factors capable of binding to their sites in chromatin. Chromatin-binding transcription factors can indirectly contribute to alterations in chromatin structure by recruiting chromatin remodeling and histone modifying coactivator proteins (1) (2) (3) (4) . More provocatively, a smaller number of transcription factors are capable of directly remodeling chromatin structure in response to environmental and/or developmental cues (5) (6) (7) (8) (9) (10) (11) . Understanding how transcription factors access their binding sites within cellular chromatin and facilitate sequential chromatin-remodeling events is essential to our understanding of the mechanisms of gene expression in the context of chromatin structure.
Certain chromatin-binding transcription factors can be grouped into larger families sharing a similar DNA binding domain, as exemplified by the forkhead (Fox) 2 DNA binding motif (12) (13) (14) (15) . All forkhead proteins contain this highly conserved "winged-helix" DNA binding domain made up of three helices and two loops or "wings" folded into a variant helixturn-helix (12) ; sequence variants of this motif define the forkhead classes FOXA-FOXQ (16, 17) . X-ray crystallography has demonstrated that the winged-helix domain of the forkhead transcription factor FoxA3 has an overall structure similar to the globular domain of the linker histones H1 and H5 (12, 18) . This structural similarity has been shown to endow certain forkhead proteins with the ability to bind their sites within condensed chromatin, a DNA context from which most other transcription factors are excluded. This is clearly seen in the case of the early developmental transcription factor FoxA1, whose ability to stably bind its sites within linker histone-compacted chromatin at the serum albumin enhancer has been shown to open the local domain to binding by additional regulatory proteins (9, 13, 19) . More recently, the signaling factor FoxI1 was shown to use its ability to remodel chromatin higher order structure to stably create or remove DNase I-hypersensitive sites in a cell-cycle-dependent fashion (15) .
Because the winged helix is a structural hallmark of all forkhead family members, it might be assumed that chromatin * The work was supported by the American Diabetes Association (Grants binding and remodeling would be an important determinant in how these proteins function. However, out of the 100 members of the forkhead gene family that have been identified to date, only a handful have been demonstrated to mediate their effects on cellular processes through chromatin remodeling (9, 14, 15, 20) . Of these, only one, FoxA, has been studied in combination with purified nucleosome templates to allow mechanistic questions to be addressed (9, 13, 19) . Additionally, structure-function analyses of the few forkhead proteins for which chromatin binding has been demonstrated have established the contribution of non-conserved protein sequences outside the forkhead box to chromatin binding and remodeling. For example, domain-swap studies have demonstrated that the forkhead domain alone does not define the differential function of the yeast transcription factors fkh1p and fkh2p in chromatin (14) , whereas in the case of FoxA1, the C terminus, in addition to the DNA binding domain, participates in high affinity core histone binding and chromatin opening by this protein (9) . It is therefore unknown whether the majority of forkhead proteins bind to and remodel chromatin, and, equally important, how their ability to do so might translate into the diverse roles in cell cycle regulation, early embryonic lineage decisions, cell differentiation, and tumorigenesis in which these factors have been implicated to date (reviewed in Ref. 17) .
Recent NMR studies demonstrating a strong structural similarity between the winged-helix motifs of the otherwise divergent FoxA and FoxO factors (21) raised the possibility that the FoxO factors might activate their target genes by binding to and remodeling chromatin structure in a similar fashion to FoxA1. This possibility was particularly exciting, because FoxO factors (FoxO1 (FKHR), FoxO3a (FKHRL1), FoxO4 (AFX), and FoxO6) regulate the expression of numerous genes, such as glucose metabolic enzymes, proapoptotic factors, and cell cycle regulators, in multiple tissues (reviewed in Refs. 22 and 23) . Additionally, the recent demonstration of FoxO1 as a potentiation factor for vascular development (24, 25) and roles for FoxO1, -3, and -4 in endothelial cell morphogenesis and hematopoietic stem cell maintenance (26, 27) suggested a need for FoxO proteins to be able to stably bind to their sites within H1-compacted chromatin.
FoxO proteins are transcription factors that bind to an insulin response element (IRE) located in the promoters of its target genes, transactivating their expression (28 -32) . FoxO factors are post-translationally modified. In response to insulin or insulin-like growth factors, protein kinase B/Akt-mediated phosphorylation of FoxO leads to its cytoplasmic retention and the inhibition of transcriptional activity (33) (34) (35) (36) (37) . In the absence of stimulation by insulin or growth factors, FoxO is de-phosphorylated and translocates into the nucleus. In the liver, target FoxO genes include the insulin-like growth factor binding protein 1 (IGFBP1), glucose 6-phosphatase, and phosphoenolpyruvate carboxykinase genes (28 -31) . In particular, the IGFBP1 gene, whose expression commences during early embryonic liver development (38) , is stimulated to high levels following liver injury and in response to glucocorticoid hormone and nutritional changes (39 -41) . DNase-hypersensitive sites, suggestive of chromatin rearrangement, have been mapped to the region of the proximal promoter of the IGFBP1 gene encompassing the two FoxO1/3 binding sites within the IRE (42) . This, together with its winged-helix DNA binding domain, suggests a role for FoxO in these perturbations. However, to date, all studies of FoxO binding have been performed using free DNA promoter fragments or binding site oligonucleotides together with recombinant FoxO proteins containing only the winged-helix domain (36, (43) (44) (45) (46) . Therefore whether and, if so, how FoxO proteins organize chromatin structure at the promoters to which they bind and the contribution of protein sequences outside the winged-helix domain to potential chromatin remodeling functions is unknown.
To address these issues we studied the binding of purified, recombinant, full-length FoxO1 protein to nucleosome particles and chromatin arrays containing the IGFBP1 promoter. We demonstrate that FoxO1 is able to bind to its cognate sites within the IGFBP1 promoter on a nucleosome and to stably disrupt core histone:DNA contacts. FoxO1 is able to harness these capabilities to bind to and de-condense linker histonecompacted chromatin arrays. Chromatin opening by FoxO1 requires both the N and C termini of the protein, which are also required for high affinity core histone binding and, in the case of the N terminus, nucleosome perturbation by this protein. This study, which implicates FoxO1 as a pioneer factor for gene activation in chromatin, provides the first demonstration of FoxO protein binding to extended and condensed chromatin structures. It is also the first to directly map chromatin-remodeling capabilities, other than chromatin opening, to amino acid sequences located outside the winged-helix domain of a forkhead protein. We suggest a model for FoxO function through potentiation and modulation of active chromatin states.
EXPERIMENTAL PROCEDURES
Plasmid Construction-The bacterial expression plasmid encoding histidine-tagged full-length FoxO1 (pET16b-10xhis-FoxO1) was created by subcloning the mouse FoxO1 cDNA (gift of Dr. Tatsuo Furuyama, Kumamoto University, Japan) in-frame into the NdeI-BamHI site of pET16b (Novagen). To generate FoxO1 truncation constructs, DNA fragments corresponding to partial amino acid sequences of FoxO1 were amplified by PCR using the following primers: FoxO1-DBD (amino acids 144 -266, 5Ј-GGG AAT TCC ATA TGG GAC AGC CGC GCA AGA CCA G-3Ј and 5Ј-CGC GGA TCC TCA CCG CCC TCG GCT CTT AGC AAA-3Ј); FoxO1-N-term (amino acids 1-150, 5Ј-GGG AAT TCC ATA TGG CCG AGG CGC CCC AGG TG-3Ј and 5Ј-CGC GGA TCC TCA GCT GGT CTT GCG CGG CTG TCC-3Ј); FoxO1-C-term (amino acids 260 -652, 5Ј-GGG AAT TCC ATA TGT TTG CTA AGA GCC GAG GGC GG-3Ј and 5Ј-CGC GGA TCC TCA GCC TGA CAC CCA GCT ATG-3Ј); FoxO1-⌬N (amino acids 144 -652, 5Ј-GGG AAT TCC ATA TGG GAC AGC CGC GCA AGA CCA G-3Ј and 5Ј-CGC GGA TCC TCA GCC TGA CAC CCA GCT ATG-3Ј); and FoxO1-⌬C (amino acids 1-266, 5Ј-GGG AAT TCC ATA TGG CCG AGG CGC CCC AGG TG-3Ј and 5Ј-CGC GGA TCC TCA CCG CCC TCG GCT CTT AGC AAA-3Ј). The PCR products were digested with NdeI and BamHI and inserted into pET-16b. To create the nucleosome array construct containing the IGFBP1 promoter, the DNA fragment corresponding to positions Ϫ371 to Ϫ11 of the mouse IGFBP1 promoter was amplified by PCR using the primers (5Ј-TGC TCT AGA CCC ACT CTT CCC TTC CCT TTG-3Ј and 5Ј-CGG ACT AGT CGT ACC CAG AGC CTT ATG AAG-3Ј), followed by digestion with NheI and SpeI and gel purification. The MluI-NcoI fragment from p208-10.N1N2P (9) was subcloned into the MluI-NcoI site of pGL3 (Promega) to create pGL3.208-10.N1N2P. pGL3.208-10.IGFBP1 was then generated by subcloning the NheI-SpeI IGFBP1 promoter DNA fragment into XbaI and SpeI digested pGL3.208-10.N1N2P in place of the N1N2P albumin enhancer sequences.
Protein Preparation-Native core histones were purified from nuclei isolated from livers of 6-month-old Sprague-Dawley rats as previously described (47) . Recombinant, high-performance liquid chromatography-purified Xenopus H2A and H2B were purchased from Upstate Biotechnologies. Recombinant, high-performance liquid chromatography-purified Xenopus H3 and H4 were the gift of Dr. Vaughn Jackson (Medical College of Wisconsin). Purity and integrity of all histone preparations (Ն95%) was confirmed by SDS-PAGE. For purification of recombinant histidine-tagged FoxO1 proteins, the pET16b-10xhis-FoxO1 plasmids were introduced into the Escherichia coli strain Rosetta (Novagen). Transformants were cultured in 250 ml of LB media and grown to A 600 ϭ 0.4 at 25°C, followed by induction of recombinant protein with 1 mM isopropyl 1-thio-␤-D-galactopyranoside. Three hours after induction, the cells were resuspended in 10 ml of dLysis buffer (50 mM TrisHCl, pH 8.0, 6 M urea, 1 mM phenylmethylsulfonyl fluoride, 1 mM DTT), and sonicated twice for 20 s. The cell lysates were centrifuged to remove cell debris and then loaded onto a 1-ml anion exchange column, Hi Trap Q FF (Amersham Biosciences) equilibrated with dLysis buffer. Flow-through fractions containing FoxO1 proteins were collected and adjusted to a final concentration of 500 mM NaCl and 10 mM imidazole and loaded onto a 2-ml His Bond Resin (Novagen) column. The column was washed with five column volumes of binding buffer (20 mM Tris-HCl, pH 7.9, 500 mM NaCl, 5 mM imidazole, 6 M urea) and three column volumes of wash buffer (20 mM TrisHCl, pH 7.9, 500 mM NaCl, 40 mM imidazole, 6 M urea). Histidine-tagged FoxO1 proteins were eluted with two column volumes of elution buffer (20 mM Tris-HCl, pH 7.9, 500 mM NaCl, 300 mM imidazole, 6 M urea), and dialyzed against 100 volumes of E. coli dialysis buffer (20 mM HEPES-KOH, pH 6.5, 400 mM KCl, 1 mM MgCl 2 , 20% glycerol, 0.1% IGEPAL, 0.5 mM phenylmethylsulfonyl fluoride, 3 mM DTT) containing 5 M urea for 16 h, followed by dialysis in the same buffer containing 4 M and 2 M urea for 2 h each. Protein concentration was determined by Bradford assay (Bio-Rad).
Assembly and Purification of Nucleosome Cores and ArraysNucleosome cores were prepared as previously described (13) . Briefly, the mouse IGFBP1 promoter DNA fragment corresponding to positions Ϫ204 to Ϫ25 was amplified by PCR using [␥
32
-P]ATP end-labeled primers (5Ј-TTA GCT CCT GTC CCA GTC CA-3Ј and 5Ј-TTA TGA AGG GCT GGC TGT G-3Ј) followed by gel purification. The 32 P-end-labeled DNA was then assembled onto purified native core histones at a DNA:histone ratio of 1:0.8 to 1:1 by salt-urea gradient dialysis. Assembled nucleosome cores were purified by glycerol gradient sedimentation and dialyzed against 10 mM Tris-HCl, pH 8.0, 1 mM 2-mercaptoethanol.
To generate the end-labeled array templates, pGL3.208-10.IGFBP1 was digested with MluI and PvuII and labeled with [␣ 32 -P]dCTP using Klenow, followed by purification of the 2.5-kb MluI-PvuII fragment. Assembly reactions containing 2 g of end-labeled fragment and core histones at a 1:1.2 molar ratio of octamers to nucleosomal sites, 1 g of BSA, and 2 M NaCl in a total of 10 l, were incubated at 37°C for 15 min, serially diluted by adding 3.3, 6.7, 5, 3.6, 4.7, 6.7, 10, 30, and 20 l of 50 mM HEPES, pH 7.5, 1 mM EDTA, 5 mM DTT, and 0.5 mM phenylmethylsulfonyl fluoride in 15-min incubation steps at 30°C, and brought to 0.1 M NaCl by adding 100 l of 10 mM Tris-HCl, pH 7.5, 1 mM EDTA, 0.1% IGEPAL, 5 mM DTT, 0.5 mM phenylmethylsulfonyl fluoride, 20% glycerol, and 100 mg/ml of BSA, followed by incubation at 30°C for 15 min.
Binding Reactions and Enzymatic Assays-Binding reactions of FoxO1 proteins to free DNA templates or nucleosome cores were performed in final buffer conditions of 10 mM Tris-HCl, pH 7.5, 1 mM MgCl 2 , 5 mM DTT, 40 mM KCl, 0.5% glycerol, 3 mg/ml BSA, and 1% Ficoll at 21-25°C for 1 h (electrophoretic mobility shift assay (EMSA), DNase I footprinting assay, and SacI digestion assays) or overnight (DNase I footprinting competition assay). For the EMSAs, the binding reactions were loaded onto 4% polyacrylamide gels in 0.5ϫ Tris-borate EDTA (TBE) buffer, followed by exposure to a phosphorimaging screen. For DNase I footprinting assays, the binding reactions were digested with 100 ng (free DNA templates) or 300 ng (nucleosome cores) of DNase I (diluted in 20 mM MgCl 2 , 1 mM CaCl 2 ) for 1 min at 21-25°C. For DNase I footprinting competition assays, 80-fold (free DNA templates, FoxO1, 0.4 pmol) or 800-fold (nucleosome cores, FoxO1, 4 pmol) excess FoxO1 binding sites of cold double-stranded oligonucleotide corresponding to the IGFBP1 promoter IRE (5Ј-AAG CAA AAC AAA CTT ATT TTG AAC-3Ј) was added to the binding reaction, and the mixture was incubated for 0, 20, and 180 s, followed by digestion with DNase I. For the SacI digestion assay, the binding reactions were diluted into 20 mM Tris acetate, pH 7.9, 10 mM magnesium acetate, 50 mM potassium acetate, 1 mM DTT and digested by the designated units of SacI for 30 min at 37°C. Digestions were stopped by addition of an equal volume of stop buffer (30 mM EDTA, 0.1% SDS, 50 mg/ml tRNA, 0.35 M NaCl), and DNA fragments were extracted with phenol/chloroform (1:1), then chloroform alone, followed by ethanol precipitation. The DNA fragments were separated on 6% polyacrylamide-7 M urea sequencing gels in 1ϫ TBE buffer and detected by both autoradiography and exposure to a phosphorimaging screen.
Binding reactions for the DNase I digestion and SpeI assays on the nucleosome arrays were carried out with 1 nM nucleosome array (13 nM nucleosomes) in final buffer conditions of 10 mM HEPES-KOH, pH 7.9, 35 mM KCl, 5 mM DTT, 4% glycerol, 0.25 mg/ml BSA. In experiments with compacted nucleosome arrays, purified mouse liver histone H1 (13 nM) was incubated with the nucleosome arrays for 1 h at 21-25°C. Purified FoxO1 proteins were then incubated with the nucleosomal or mock assembled substrates for 1 h at 21-25°C. DNase I digestions were performed by adding 40 or 80 ng of DNase I (diluted in 50 mM MgCl 2 ), followed by incubation at 21-25°C for 1 min. SpeI digestion was carried out in 6 mM HEPES-KOH, pH 7.5, 35 mM KCl, 5 mM MgCl 2 , 5 mM DTT, 0.25 mg/ml BSA at 37°C for 45 min. Digestion reactions were stopped by addition of an equal volume of 20 mM Tris-HCl, pH 7.5, 30 mM EDTA, 0.1% SDS, 25 mg/ml tRNA, 0.2 mg/ml Proteinase K and incubated at 50°C for 1 h. DNA fragments were purified by ethanol precipitation and separated on a 1% agarose gel in 0.5ϫ TBE buffer. Gels were fixed in 10% acetic acid, 10% methanol and dried, followed by exposure to a phosphorimaging screen. For chromatosome assays, extended or H1-compacted nucleosome arrays were digested with the designated units of micrococcal nuclease (diluted in 30 mM CaCl 2 ) in 10 mM HEPES-KOH, pH 7.9, 35 mM KCl, 5 mM DTT, 4% glycerol, 0.25 mg/ml BSA for 1 min at 21-25°C. Digestions were stopped by addition of an equal volume of stop buffer (30 mM EDTA, 0.1% SDS, 0.35 M NaCl, 0.2 mg/ml Proteinase K) and then incubated for 1 h at 50°C. DNA fragments were extracted with phenol/chloroform (1:1), then chloroform alone, followed by ethanol precipitation. The DNA fragments were run on 8% polyacrylamide gels in 1ϫ TBE buffer and stained with ethidium bromide.
Core Histone Binding Assays-Purified native (8 g) or recombinant core histones (3 g) were incubated with 10 l of beads alone (mock) or FoxO1 protein-bound beads, the latter containing ϳ1 mg of bound protein per 1 ml of beads, in binding buffer (10 mM Tris-HCl, pH 7.5, 1 mM MgCl 2 , 150 mM NaCl, 1% Ficoll, 0.1% IGEPAL, 20 mM imidazole) for 30 min at 21-25°C. The beads were washed five times with binding buffer containing 150 mM NaCl, and then subjected to successive washes containing 300 and 600 mM NaCl. The washed fractions and beads (bound fraction, B) were added to SDS sample buffer, run on 13.5% SDS-PAGE, and stained with Coomassie Blue or silver using a silver stain kit from Bio-Rad.
RESULTS

FoxO1 Binds to Its Sites on the IGFBP1 Promoter Assembled into a Nucleosome
Particle-We assembled nucleosome core particles from purified core histone proteins and 180-bp endlabeled DNA fragments containing mouse IGFBP1 promoter sequences (Ϫ204 to Ϫ25). In addition to the IRE, which contains a direct repeat of the FoxO1 binding site, this promoter fragment contains a binding site for the transcription factor HNF-1 and two binding sites for the glucocorticoid receptor (Fig. 1A) (39) . This sequence was specifically selected to ascertain that, following nucleosome assembly, the IRE would be centrally located at or near the pseudodyad axis of symmetry on the resulting nucleosome particles. This would confirm that FoxO1 binding to the IRE on these particles is nucleosomal. The nucleosome cores were purified as previously described (13) and are illustrated in Fig. 1B . SDS-PAGE analysis of the products of the nucleosome assembly reactions confirmed the presence of nucleosome cores containing the expected equimolar ratio of input core histones (Fig. 1C, lanes 4 -6) .
To examine the ability of FoxO1 to bind to its sites on a nucleosome, we performed DNase I footprinting ( Fig. 2B ) with full-length mouse FoxO1 prepared as a recombinant protein fused to a 10ϫ polyhistidine tag (Fig. 2A, lane 2) . FoxO1 bound to both of its previously characterized binding sites within the IRE (Fig. 2B , lanes 4 -6, downstream label, and lanes 10 -12, upstream label) on the nucleosome cores as indicated by the extended region of protected bands (IRE, brackets to the right of each panel); FoxO1 also bound to the IRE on the corresponding free DNA templates (Fig. 2B, lanes 1-3, downstream label, and lanes 7-9, upstream label). Furthermore, EMSA showed that FoxO1-nucleosome core complexes migrated more slowly than FoxO1-free DNA complexes, indicating formation of higher molecular weight complexes consisting of FoxO1 bound to its two IRE and single FNBS (see below) sites on the nucleosome cores (Fig. 2C, compare lanes 1-3 with lanes 4 -8) . In these assays, ϳ10-fold more FoxO1 was required to bind the same amount of nucleosome cores as free promoter DNA; this lowered affinity for nucleosomal DNA binding has been previously described for other transcription factors (13, 48) . We conclude from these experiments that FoxO1 is able to bind to the IRE on a nucleosome and form integral FoxO1-nucleosome complexes.
An additional FoxO1 footprint was also reproducibly observed ϳ60 bp upstream of the IRE, on both the free DNA and nucleosome templates (Fig. 2B , FNBS, FoxO1 new binding site, bracket to right of each panel). This footprint, which corresponds to a single canonical FoxO1 binding site "ACAAACA," maps within the linker DNA just beyond the edge of the nucleosome particle. Subsequent footprinting experiments demonstrated that FoxO1 is able to bind to a single FNBS site assembled near the dyad axis of nucleosome cores (data not shown).
Stable Nucleosome Binding by FoxO1 Disrupts Core Histone: DNA Contacts-A close examination of the footprinting gels in Fig. 2B showed that the binding of FoxO1 to the IRE on the nucleosome particles, but not the corresponding free DNA templates, generated an extended region of DNase hypersensitivity extending upstream and downstream of its footprints. Some of the hypersensitive sites represented, in enhanced form, cleavages already present on the nucleosome cores in the absence of FoxO1 binding (dots to right of each gel). These enhanced cleavages occur at 10-bp intervals indicative of nucleosome positioning, or phasing of DNA on the nucleosome particle, suggesting that binding of FoxO1 enforces a distinct rotational position on DNA wrapped around the nucleosome particle. Interspersed among these cleavages were additional hypersensitive sites barely evident on the unbound nucleosome cores (arrows to right of each gel). This second set of hypersensitive sites suggested extensive perturbation of core histone: DNA contacts by FoxO1. To explore this phenomenon further, we probed FoxO1-bound nucleosome cores with the restriction enzyme SacI, whose recognition site mapped to a region of maximal perturbation upstream of the IRE. As shown in Fig.  2D , FoxO1 binding to nucleosome cores increased their accessibility to digestion with SacI (compare lanes 4 -6 to lanes 1-3) . We concluded that FoxO1 binding perturbs core histone:DNA contacts on nucleosome cores.
The perturbations in core histone:DNA contacts suggested by the DNase footprinting data raised the question of whether the FoxO1 bound nucleosome cores were disrupted. Several pieces of data argued in favor of intact cores. The 10-bp ladder of hypersensitive sites indicative of a phased nucleosome is evident outside the region of perturbation. Additionally, even at the highest amounts of FoxO1 used, we did not observe disruption of nucleosome cores in the form of the release of free DNA in the gel shift assay (Fig. 2C, lanes 7 and 8) . As a final test, we performed a DNase competition assay previously used to demonstrate stable nucleosome binding and positioning by FoxA1 (19) . Mixtures of FoxO1 and 32 P end-labeled IGFBP1 mononucleosomes (or the corresponding free DNA control) were allowed to reach binding equilibrium. At various times thereafter, the reactions were challenged with a molar excess of unlabeled FoxO1 binding site oligonucleotide, followed by DNase I footprinting analysis. A 10-fold higher concentration of binding site oligonucleotide was used to compete FoxO1 from the nucleosome as compared with the free DNA templates to account for the 10-fold higher amount of FoxO1 required for optimal binding to its IRE binding sites on the nucleosome cores. As seen in Fig. 3B, FoxO1 selectively protects the IRE on free DNA (lane 2) and nucleosome templates (lane 6). Twenty seconds after the addition of competitor DNA, most of the FoxO1 was released from the free DNA templates (Fig. 3B, lane  3) , indicating that the binding complex has a short half-life. In contrast, virtually all of the FoxO1 binding site protections were observed on the nucleosomes after 3 min of incubation with competitor (Fig. 3B, lane 8) . Additionally, the DNase-hypersensitive sites generated by FoxO1 binding, indicative of nucleosome positioning and core histone:DNA perturbations, also persisted throughout the competition assay (dots and arrows, respectively, to right of lane 8) . Complete disruption of the nucleosome cores following FoxO1 binding would have released free DNA and core histones. FoxO1 bound to free DNA released from disrupted nucleosome particles would have been expected to behave identically to the FoxO1 bound to the free DNA templates; that is, we would have expected to see the loss of FoxO1-mediated protections and hypersensitive sites following incubation of FoxO1-disrupted nucleosomes with oligonucleotide competitor. We therefore conclude from these experiments that stable nucleosome binding by FoxO1 perturbs core histone:DNA contacts and reinforces a distinct, stable change in the rotational position of DNA wrapped around the nucleosome particle.
FoxO1 Opens H1-compacted Nucleosome Arrays Containing the IGFBP1 Promoter-As mentioned in the introduction above, DNase I mapping experiments had previously revealed the presence of hypersensitive sites at the proximal IGFBP1 promoter in mouse liver (42) , indicating that the perturbations in core histone:DNA contacts generated by FoxO1 binding to its sites at the IGFBP1 promoter assembled onto nucleosome cores in vitro might be physiologically relevant. Additionally, recently demonstrated roles for FoxO proteins in endothelial cell morphogenesis and hematopoietic stem cell maintenance (26, 27) suggested the ability of FoxO1 to stably bind to its sites within H1-compacted chromatin. To examine this possibility in vitro, we assembled nucleosome arrays containing the IGFBP1 promoter that could be compacted with the linker histone (9, 49) . The array template consists of a dinucleosomesized mouse IGFBP1 promoter sequence encompassing the promoter fragment used to assemble the mononucleosome templates (Ϫ371 to Ϫ11), flanked on either side by five copies of a sea urchin 5 S rDNA nucleosome-positioning sequence (Fig.  4A) . Nucleosome arrays were assembled from end-labeled DNA templates and purified native core histones. The extended nucleosome arrays migrated as a discrete band and slightly faster than free DNA templates on a native agarose gel (compare lanes 2 and 3 to lane 1 in Fig. 4B ) as expected (50) . The extended arrays were also compacted by incubating them with linker histone H1 at a 1:1 molar ratio to nucleosomes. Appropriate assembly of linker histone into the arrays was determined by observing a digestion intermediate of ϳ165 bp, or "chromatosome," upon digestion with micrococcal nuclease (Fig. 4C, lanes 2 and 3) . Partial digestion of the extended arrays with DNase I revealed cleavages and protections indicative of 12 evenly spaced nucleosomes (Fig. 4D, lanes 4 -6) . H1 compaction of the extended nucleosome arrays made the arrays resistant to amounts of DNase I that completely digested the extended arrays (Fig. 4D, compare lanes 7-9 with 4 -6) . In summary, these data show that we created extended and H1-compacted arrays containing IGFBP1 promoter sequences.
To examine the effect of FoxO1 binding to the extended and H1-compacted arrays, we performed DNase I-hypersensitive site analysis with end-labeled arrays. Somewhat surprisingly, FoxO1 binding to the extended arrays showed no distinct perturbations in the chromatin structure corresponding to the IGFBP1 promoter (compare lanes 1 and 2 to lanes 3 and 4 in Fig.  5A ). In fact, FoxO1 appeared to slightly inhibit DNase digestion of the nucleosome arrays. In contrast, DNase I digestion of the H1-compacted arrays incubated with FoxO1 evinced DNase I-hypersensitive sites, indicative of chromatin opening, at the IGFBP1 promoter region (Fig. 5A, lanes 7 and 8) . To assess chromatin opening differently, we employed a restriction enzyme accessibility assay. A recognition site for SpeI is located within the linker region between the 3Ј-end of the IGFBP1 promoter sequences and the sea urchin 5 S rDNA sequences (Fig.  4A ). In agreement with the results of the DNase I digestion assay, FoxO1 binding increased the ability of SpeI to digest the H1-compacted arrays (compare lanes 3 and 4 to lanes 1 and 2 in Fig. 5B ). We conclude that FoxO1 is able to access and open up linker histone-compacted chromatin containing the IGFPB1 promoter. (lanes 1-3) , extended nucleosome arrays (lanes 4 -6) , and H1-compacted nucleosome arrays (lanes 7-9) were digested with the indicated amounts of DNase I. Positions of nucleosomes on reconstituted arrays is indicated to the left of gel. Lane E, partial EcoRI digest of end-labeled array fragment.
FoxO1 N and C Termini Are Required for Efficient Chromatin
Opening-Structure-function analyses of the chromatin-opening protein FoxA1 have established the contribution of protein sequences outside the winged-helix motif to chromatin opening by this protein (9) . To determine if the winged-helix portion of FoxO1 is sufficient for chromatin opening, or if contributions from additional protein domains are required, we performed the DNase I assay with the H1-compacted arrays using wild-type and deletion mutant forms of FoxO1 (Fig. 6A) . Although the full-length FoxO1 protein generated overt hypersensitive sites characteristic of chromatin opening (Fig. 6B, lane  4) , truncation mutants containing only the central winged-helix DNA binding domain failed to open the nucleosome arrays (DBD; lanes 7 and 8). Mutants missing the N terminus (⌬N; lanes 13 and 14) , exhibited weak chromatin opening ability, and to lesser extent, so did mutants missing the C terminus (⌬C; lanes 11 and 12) . This suggested that one or more protein domain(s) within the FoxO1 N and C termini cooperate to open chromatin. As expected, the protein fragments containing the FoxO1 N and C termini alone failed to open chromatin (lanes 5-6 and 9 -10, respectively).
FoxO1 N Terminus Is Required for FoxO1-mediated Core Histone:DNA Perturbations-One possible explanation for the inability of the DBD to open chromatin on its own, and for the deficiency in chromatin opening exhibited by the N-and C-terminal truncation mutants, was that the N and C termini stabilize high affinity binding of the DBD to a nucleosome. To assess this possibility, we compared DNase I footprinting of the fulllength and truncated FoxO1 proteins on nucleosome cores. As shown in Fig. 7 (A and B) , the full-length (lanes 2-4), ⌬C (lanes  8 -10) , and ⌬N (lanes 11-13) FoxO1 proteins bound with approximately equal affinity to the IRE at the IGFBP1 promoter assembled onto nucleosome particles, whereas truncation mutants containing the DNA binding domain alone (lanes 5-7) bound with somewhat weaker affinity. However, in a DNase competition assay (Fig. 7C) , the DBD fragment (lanes 5-7) exhibited a similar off-rate from the IRE on the nucleosome particles compared with that of the full-length (lanes 2-4) and the ⌬C (lanes 8 -10) and ⌬N (lanes 11-13) truncated proteins. Despite this, binding by the FoxO1 DBD and the ⌬N mutant, but not full-length FoxO1 or the ⌬C mutant, failed to generate the DNase-hypersensitive sites, indicative of nucleosome positioning and perturbation of core histone:DNA contacts, extending up and downstream from the IRE (compare DNase cleavages in lanes 5-7 and 11-13 to lanes 2-4 and 8 -10 in Fig.  7 , A and B, indicated by dots and arrows, respectively, to the right of the footprinting gels). In agreement with this result, whereas binding of the full-length (Fig. 7D, lanes 4 -6) and ⌬C (lanes 10 -12) FoxO1 proteins led to enhanced SacI digestion of the nucleosome cores, binding of the DBD (lanes 7-9) and ⌬N proteins (lanes 13-15) did not. In summary, we conclude that, although the FoxO1 winged-helix DNA binding domain is sufficient for nucleosome binding, the FoxO1 N terminus confers the ability of the FoxO1 protein to perturb core histone:DNA contacts and reinforce nucleosome position subsequent to stable nucleosome binding. 1-4) or nucleosome arrays compacted with a 1:1 molar ratio of linker histone (lanes 5-8) and 100 nM FoxO1. Location of the nucleosomes corresponding to the IGFBP1 promoter is indicated to the left of the gel. The arrowhead to the right of the gel denotes the position of the major hypersensitive sites induced by FoxO1 opening of H1-compacted nucleosome arrays. Lane E, partial EcoRI digest of end-labeled array fragment. B, SpeI accessibility assay of FoxO1 bound to H1-compacted IGFBP1 promoter nucleosome arrays. The reactions contained 100 nM FoxO1 and were digested with the indicated amounts of SpeI. The arrowhead to the right of the gel denotes the position of the expected SpeI digestion product. 
FoxO1 N and C Termini Direct High Affinity Core Histone
Binding-Previous studies suggested that the core histone proteins could provide a nucleosomal target for chromatin opening (9, 51) . To explore this possibility for FoxO1, we covalently linked wild-type and mutant forms of polyhistidine-tagged FoxO1 to Ni ϩ -agarose beads and then assessed the proteins' ability to bind to native and recombinant core histone proteins. In binding assays performed using native core histones, wild-type FoxO1 bound efficiently to a complex of histones H3 and H4 (Fig. 8A,  lane 5 ). This binding was resistant to 0.6 M salt. In contrast, histones H2A and H2B did not bind to FoxO1 under these conditions but were released in the 0.3 and 0.6 M salt washes (lanes 3 and 4) . The Ni ϩ -agarose beads alone failed to bind core histones (lanes 6 -9) . Under the initial wash conditions employed in these assays (150 mM NaCl, pH 7.5), histones H3 and H4 exist as stable (H3/H4) 2 tetramers (52, 53) . To determine whether FoxO1 bound to histones H3 and H4 individually we carried out the same binding assay with recombinant H3 and H4 proteins, and, as a control, recombinant H2A and H2B. FoxO1 bound efficiently to both recombinant H3 and H4 (Fig.  8B, lanes 4, bottom two panels) 6 and 7) . Finally, to determine which of the one or more portions of FoxO1 bind to histones H3 and H4, we tested the core histone-binding ability of the truncation mutants. Like the full-length protein, the FoxO1 N-and C-terminal domains bound efficiently to histones H3 (Fig. 8C, lanes 7 , upper and lower panels, respectively) and H4 (Fig. 8D, lanes 7, upper and  lower panels, respectively) . In contrast, the truncation mutant containing the DNA binding domain alone bound weakly to histone H3 (Fig. 8C, lane 4) and still more weakly to H4 (Fig. 8D, lane 4) . We conclude from these experiments that the N-and C-terminal domains of FoxO1, which together are required for optimal chromatin opening, confer core histone binding on FoxO1.
DISCUSSION
The results described in this report provide the first demonstration of FoxO protein binding and remodeling of extended and condensed chromatin structures and are the first to directly 1, 4, 7, 10, and 13) , 5 (lanes 2, 5, 8, 11, and 14) , and 10 (lanes 3, 6, 9, 12, and 15) units of SacI. Arrowhead indicates expected SacI digestion product.
map nucleosome-binding capabilities, other than chromatin opening, to amino acid sequences outside the winged-helix domain of a forkhead protein. We suggest that the chromatinbinding and -remodeling functions revealed for FoxO1 in this study endow FoxO factors with the ability to initiate and dynamically modulate active chromatin states, thereby enabling their diverse physiological functions.
We demonstrated that FoxO1 uses its N and C termini to open chromatin (Fig. 6B) and bind directly to histones H3 and H4 (Fig. 8, C and D) . This binding is resistant to 0.6 M salt, indicating that the interaction is quite strong. We suggest that direct interactions between FoxO1 and core histones at gene regulatory regions perturb histone:histone and histone:DNA contacts; both of these activities would make adjacent chromatin more accessible to other proteins, potentiating an active chromatin state. Linker histone binding alters key core histone interactions with DNA wrapped around the nucleosome particle. In particular, linker histone binding has been shown to strengthen binding of histone H4 to regions of sharply bent nucleosomal DNA located near the dyad axis of the nucleosome particle (54); these contacts impede factor binding to DNA. Stable binding of FoxO1 to nucleosome cores formerly occupied by the linker histone during chromatin opening would be expected to disable these core-histone:DNA contacts, opening up the structure. In addition to these intra-nucleosomal contacts, histones H3 and H4 also make inter-nucleosomal contacts, which have been implicated in the formation of nucleosomal arrays (55) . By interrupting these inter-nucleosomal interactions, FoxO1 binding could locally de-compact the array and make it accessible to recruitment and binding of additional proteins.
The N-and C-terminal protein fragments of FoxO1 showed the same histone-binding characteristics in the in vitro histone binding assay; however, neither fragment alone was able to open chromatin (Fig. 6B) . This suggests that the DBD must target the N-and C-terminal domains to specific sites on nucleosome particles to open chromatin, similar to what has previously been demonstrated for FoxA1 (9) . Unlike the FoxA1 protein, where chromatin opening mapped to a single protein domain (9) , chromatin opening by FoxO1 requires amino acid sequences located within both the N-and C-terminal domains of the protein, suggesting that, in addition to core histone binding, these domains contribute different, complementary functions to the chromatin-opening process. The DNase footprinting assays shown in Fig. 7 (A and B) and the DNase competition assay shown in Fig. 7C demonstrate the loss of stable nucleosome position and perturbation of core:histone DNA contacts by the ⌬N truncation mutant, suggesting a predominant role for the FoxO1 N terminus in both of these functions: core histone binding by the N terminus could contribute to either activity. As has been suggested for FoxA1, stable nucleosome positioning by FoxO1 might create alterations in linker DNA lengths on either side of the nucleosome to which it is bound, which would in turn facilitate the process of chromatin de-compaction. Small variations in linker length can trigger changes in nucleosome compaction (56); therefore, failure to effect these alterations could account for the deficit in chromatin de-compaction observed for the ⌬N mutant.
In contrast to the ⌬N mutant, the nucleosome perturbation capabilities of the ⌬C truncation mutant are similar to those of the wild-type, full-length FoxO1 protein. However, the ⌬C truncation mutant is almost completely deficient in chromatin de-compaction, suggesting that this domain carries out an essential, as yet unknown, function in this process. Fusion proteins containing the human counterpart of the FoxO1 C-terminal domain and the DNA binding domain of the transcription factor PAX3 (PAX3:FKHR) have been identified in rhabdomyosarcoma, where it is required for cellular transformation (57) (58) (59) . Studies in our laboratory have shown that the FoxO1 C-terminal region does not confer chromatin-opening ability on Beads were subjected to five washes with 150 mM NaCl, followed by a more stringent wash with 600 mM NaCl. B lanes indicate bound (beads) fractions. The gels were stained with silver. Input, input core histones.
PAX3:FKHR, (data not shown), supporting the idea that multiple FoxO1 domains carry out complimentary functions culminating in chromatin opening. The FoxO1 C-terminal domain contains two sequences highly conserved among FoxO, but not FoxA, family members across multiple species, referred to as CR2 and CR3 (57) . The highly acidic CR3 functions as a potent transactivation domain and recruits the core histone acetyltransferase CBP/p300 (60), whereas CR2, which is predicted to contain three small conserved ␣-helical segments of unknown function (57) , recruits Sirt1, a histone deacetylase targeting both the core histones and histone H1 (61, 62) . The ability to bind within H1-compacted chromatin, together with core histone binding, might allow the FoxO1 C terminus to function as a platform for chromatin-remodeling enzymes to facilitate chromatin modification in vivo, in addition to its roles in chromatin opening.
DNase I mapping analysis previously conducted on the IGFBP1 promoter in mouse liver nuclei demonstrated liverspecific DNase I-hypersensitive sites mapping to the proximal IGFBP1 promoter region extending from Ϫ300 to Ϫ100 (42) . In this study, we found that FoxO1 binding to its sites within nucleosome particles and H1-compacted arrays encompassing this region generated DNase-hypersensitive sites indicative of core histone:DNA perturbations and chromatin opening, respectively, suggesting that binding of FoxO1 to its sites at the IGFBP1 promoter might generate the corresponding changes in liver chromatin in vivo. The widespread perturbation of core histone:DNA contacts generated by FoxO1 binding and mapping to the FoxO1 N-terminal domain has previously been reported for the transcription factors GAL4 (63), GATA-1 (7), and Amt1 (64) . Like GATA-1 and Amt1, and unlike GAL4, FoxO1-mediated core histone:DNA perturbations do not appear to completely disrupt the underlying nucleosome cores, because we did not observe the expected release of free DNA indicative of nucleosome disruption upon binding of FoxO1 to nucleosome particles in either the gel shift (Fig. 2C) or DNase competition assay (Fig. 3B) . Also, unlike Amt1, for which perturbation necessitates binding at the dyad axis of the nucleosome, and GATA-1 and GAL4, for which perturbation requires binding to multiple sites, the ability of FoxO1 to perturb core histone:DNA contacts appears to be independent of both the number and location of its binding sites on nucleosomal DNA, because the same perturbations are observed when the FoxO1 IRE is moved farther away from the nucleosome dyad axis and on nucleosomes containing a single FoxO1 binding site (data not shown).
In summary, we suggest that the chromatin-binding and -remodeling capabilities exhibited by FoxO1 reflect a potential role for FoxO1 in gene activation events, similar to what has been demonstrated for the FoxA (9, 65, 66) and other nucleosome-binding transcription factors (5, 6, 10, 11) . Stable chromatin binding and opening, combined with the ability to reinforce nucleosome position and perturb core:histone DNA contacts, would allow FoxO1 to "potentiate" an active chromatin environment, facilitating the binding/loading of additional transcription factors and the recruitment of the pre-initiation complex to the IGFPB1 promoter. The ability of FoxO1 to recruit histone acetyltransferase activity would further its chromatin-potentiating functions (60) , whereas its enhanced perturbation capabilities might enable the rapid formation/dissolution of active complexes required for timely responses to hormonal and nutritional needs. FoxO factors have been shown to play important roles in mediating the effects of insulin and growth factors on cell proliferation, apoptosis, and metabolism (22, 23) and are essential for vascular development (24, 25) , endothelial cell morphogenesis, and hematopoietic stem cell maintenance (26) . The ability of FoxO1 and, by implication, other FoxO factors, to initiate and dynamically modulate active chromatin states in response to developmental and extracellular cues therefore has global implications for a wide array of developmental and physiological processes.
